ICCA의 화학제품-내분비계 장애물질에 관한 산업계 대응상황에 대한 보고
2014.08.21 6814
현재 ICCA (미국ACC, 유럽Cefic)측에서는 WHO-UNEP의 "12년도 제2차 화학제품-내분비계 장애물질보고서"에 관하여
ECPA, CropLife America, CropLife Canada, CropLife International와 공동으로`13년도부터 글로벌 화학산업계를 대표하여
현재 대응 중입니다.
그에 관한 논문, ICCA 공동입장표명서와 UNEP의 회신서를 첨부 알려드립니다.
기타관련 사항 더 많은 정보를 원하시는 분은 본 사무국으로 연락바랍니다.
*첨부(3)
- Regulatory Toxicology and Pharmacology
- ICCA CropLife joint letter to WHO and UNEP re Endocrine Disrupting Chemicals
- Letter to Mr Mandery
Sent: Wednesday, August 20, 2014 11:14 PM
Subject: ICCA CP&H LG - Update: UNEP reply to ICCA/CLI letter on endocrines
To: ICCA Chemical Policy & Health LG
in a joint letter to UNEP and WHO, Crop Life International and ICCA announced the release of the industry-funded Critical comments on the WHO-UNEP State of the Science of Endocrine
Disrupting Chemicals (for further information, please visit http://www.sciencedirect.com/science/article/pii/S0273230014000269). Please find UNEP`s response letter attached below.
Kind Regards / Mit freundlichen Grüßen
Dr. Anna Hitschler
Global Product Strategy (GPS)
in a joint letter to UNEP and WHO, Crop Life International and ICCA announced the release of the industry-funded Critical comments on the WHO-UNEP State of the Science of Endocrine
Disrupting Chemicals (for further information, please visit http://www.sciencedirect.com/science/article/pii/S0273230014000269). Please find UNEP`s response letter attached below.
Kind Regards / Mit freundlichen Grüßen
Dr. Anna Hitschler
Global Product Strategy (GPS)
BASF - The Chemical Company
